Free market model

A ‘global revolution’ must occur in new cancer drug pricing if the world is to cope with the growing instances of the disease. That is the stark finding of a study published on Tuesday in the journal Nature Reviews. “It is very clear that pharmaceutical companies charge far too much, often blaming Read more…